Mode
Text Size
Log in / Sign up
N/A N=142 Randomized Treatment

Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery

Urinary Retention

Enrolled (actual)
142
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcome: Primary: Number of Participants With Acute Urinary Retention — 6; 7 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Prazosin given 6 hours prior to catheter removal in the 24 hour group (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Cedars-Sinai Medical Center
Primary completion
Nov 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Acute Urinary Retention
6; 7
SECONDARY
Number of Participants With a Symptomatic Urinary Tract Infection
0; 8 <0.05 sig

Summary

There is no general agreement about the optimal duration of postoperative urinary drainage, with relevant literature reporting durations ranging from 1 to 10 days. The available research supporting the routine use of prolonged catheterization is limited and studies investigating early removal following infraperitoneal colorectal surgery have largely been underpowered to form valid practice conclusions. The aim of the investigators study is to determine whether a postoperative colorectal patient can safely have an indwelling catheter removed on postoperative day one (24 hours following surgery) with the addition of a study medication (prazosin), without a statistically significant difference in the incidence of urinary retention compared to the standard, accepted approach of delayed removal (72 hours postoperatively). Patients undergoing laparoscopic and open pelvic colorectal surgery below the peritoneal reflection for both benign and malignant conditions will be randomized into two groups: group one will have the catheter removed on postoperative day 3 (72 hours postoperatively) Group 2 will have a dose of the alpha-blocker prazosin given 6 hours prior to catheter removal and will have the urinary catheter removed on postoperative day 1 (24 hours postoperatively).

Eligibility Criteria

Inclusion Criteria

  • Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
  • Males or females, >18 years of age inclusive at the time of study screening;
  • American Society of Anesthesiologists (ASA) Class I-III;
  • Infraperitoneal colorectal surgery (open and/or laparoscopic);
  • Elective Surgery

Exclusion Criteria

  • Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures;
  • Children 2
  • Diagnosis of benign prostatic hyperplasia
  • Chronic urinary infections
  • Neurogenic bladder
  • History of enterovesical fistula
  • Pregnancy
  • Prior surgery of the lower urinary tract
  • Epidural
  • Perioperative ureteral stents

After randomization:

  • Catheter pulled out inadvertently;
  • Postoperative complications requiring prolonged monitoring of urine output
  • Postoperative complications requiring early reoperation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01923129). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search